Influence of age on the relationship between apixaban concentration and anti-factor Xa activity in older patients with non-valvular atrial fibrillation

Kalaria, Shamir N.; Zhu, Hao; Liu, Qi; Florian, Jeffrey; Wang, Yaning; Schwartz, Janice

doi:10.1016/j.ijcard.2021.01.025

Influence of age on the relationship between apixaban concentration and anti-factor Xa activity in older patients with non-valvular atrial fibrillation

Journal Article · Sat May 01 00:00:00 EDT 2021 · International Journal of Cardiology

DOI:https://doi.org/10.1016/j.ijcard.2021.01.025· OSTI ID:1809345

Kalaria, Shamir N.; Zhu, Hao; Liu, Qi; Florian, Jeffrey; Wang, Yaning; Schwartz, Janice

Not Available

View Accepted Manuscript (Publisher)

Sponsoring Organization:: USDOE

OSTI ID:: 1809345

Journal Information:: International Journal of Cardiology, Journal Name: International Journal of Cardiology Journal Issue: C Vol. 331; ISSN 0167-5273

Publisher:: ElsevierCopyright Statement

Country of Publication:: Netherlands

Language:: English

References (24)

Population Pharmacokinetics of Apixaban in Subjects With Nonvalvular Atrial Fibrillation Cirincione, Brenda; Kowalski, Kenneth; Nielsen, Jace CPT: Pharmacometrics & Systems Pharmacology, Vol. 7, Issue 11 https://doi.org/10.1002/psp4.12347	journal	September 2018
Differences in Warfarin Pharmacodynamics and Predictors of Response Among Three Racial Populations Ohara, Minami; Suzuki, Yasuhiko; Shinohara, Saki Clinical Pharmacokinetics, Vol. 58, Issue 8 https://doi.org/10.1007/s40262-019-00745-5	journal	February 2019
Apixaban Levels in Octogenarian Patients with Non-valvular Atrial Fibrillation Nissan, Ran; Spectre, Galia; Hershkovitz, Avital Drugs & Aging, Vol. 36, Issue 2 https://doi.org/10.1007/s40266-018-0613-8	journal	November 2018
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Ruff, Christian T.; Giugliano, Robert P.; Braunwald, Eugene The Lancet, Vol. 383, Issue 9921 https://doi.org/10.1016/S0140-6736(13)62343-0	journal	March 2014
Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial Ruff, Christian T.; Giugliano, Robert P.; Braunwald, Eugene The Lancet, Vol. 385, Issue 9984 https://doi.org/10.1016/S0140-6736(14)61943-7	journal	June 2015
Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale Lopes, Renato D.; Alexander, John H.; Al-Khatib, Sana M. American Heart Journal, Vol. 159, Issue 3 https://doi.org/10.1016/j.ahj.2009.07.035	journal	March 2010
Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants Cuker, Adam; Siegal, Deborah M.; Crowther, Mark A. Journal of the American College of Cardiology, Vol. 64, Issue 11 https://doi.org/10.1016/j.jacc.2014.05.065	journal	September 2014
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation January, Craig T.; Wann, L. Samuel; Calkins, Hugh Journal of the American College of Cardiology, Vol. 74, Issue 1 https://doi.org/10.1016/j.jacc.2019.01.011	journal	July 2019
Plasma Apixaban Levels in Patients Treated Off Label With the Lower Dose Bhagirath, Vinai C.; Chan, Noel; Hirsh, Jack Journal of the American College of Cardiology, Vol. 76, Issue 24 https://doi.org/10.1016/j.jacc.2020.09.615	journal	December 2020
Failure of Pharmacogenetic-based Dosing Algorithms to Identify Older Patients Requiring Low Daily Doses of Warfarin Schwartz, Janice B.; Kane, Lynn; Moore, Kelly Journal of the American Medical Directors Association, Vol. 12, Issue 9 https://doi.org/10.1016/j.jamda.2010.12.006	journal	November 2011
International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants Gosselin, Robert; Adcock, Dorothy; Bates, Shannon Thrombosis and Haemostasis, Vol. 118, Issue 03 https://doi.org/10.1055/s-0038-1627480	journal	February 2018
Apixaban versus Warfarin in Patients with Atrial Fibrillation Granger, Christopher B.; Alexander, John H.; McMurray, John J. V. New England Journal of Medicine, Vol. 365, Issue 11 https://doi.org/10.1056/NEJMoa1107039	journal	September 2011
Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial Halvorsen, S.; Atar, D.; Yang, H. European Heart Journal, Vol. 35, Issue 28 https://doi.org/10.1093/eurheartj/ehu046	journal	February 2014
Incidence of direct oral anticoagulant use in patients with nonvalvular atrial fibrillation and characteristics of users in 6 European countries (2008–2015): A cross‐national drug utilization study Ibáñez, Luisa; Sabaté, Mònica; Vidal, Xavier British Journal of Clinical Pharmacology, Vol. 85, Issue 11 https://doi.org/10.1111/bcp.14071	journal	September 2019
Apixaban Concentrations with Lower than Recommended Dosing in Older Adults with Atrial Fibrillation Sukumar, Smrithi; Gulilat, Markus; Linton, Bradley Journal of the American Geriatrics Society, Vol. 67, Issue 9 https://doi.org/10.1111/jgs.15982	journal	May 2019
When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH Levy, J. H.; Ageno, W.; Chan, N. C. Journal of Thrombosis and Haemostasis, Vol. 14, Issue 3 https://doi.org/10.1111/jth.13227	journal	February 2016
Low drug levels and thrombotic complications in high‐risk atrial fibrillation patients treated with direct oral anticoagulants Testa, S.; Paoletti, O.; Legnani, C. Journal of Thrombosis and Haemostasis, Vol. 16, Issue 5 https://doi.org/10.1111/jth.14001	journal	April 2018
Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants Testa, Sophie; Legnani, Cristina; Antonucci, Emilia Journal of Thrombosis and Haemostasis, Vol. 17, Issue 7 https://doi.org/10.1111/jth.14457	journal	May 2019
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients: The ARISTOPHANES Study Lip, Gregory Y. H.; Keshishian, Allison; Li, Xiaoyan Stroke, Vol. 49, Issue 12 https://doi.org/10.1161/STROKEAHA.118.020232	journal	December 2018
Chromogenic anti-FXa assay calibrated with low molecular weight heparin in patients treated with rivaroxaban and apixaban: possibilities and limitations Ćelap, Ivana; Bašić Kes, Vanja; Lovrenčić-Huzjan, Arijana Biochemia medica, Vol. 30, Issue 1 https://doi.org/10.11613/BM.2020.010702	journal	February 2020
Relationship between time spent at extreme International Normalized Ratios and time in therapeutic range with bleeding and thrombosis in warfarin-treated patients Barta, Ashley L.; Nutescu, Edith A.; Thompson, Paul A. American Journal of Health-System Pharmacy, Vol. 72, Issue 14 https://doi.org/10.2146/ajhp140752	journal	July 2015
Factors influencing warfarin dose requirements in African–Americans Momary, Kathryn M.; Shapiro, Nancy L.; Viana, Marlos AG Pharmacogenomics, Vol. 8, Issue 11 https://doi.org/10.2217/14622416.8.11.1535	journal	November 2007
LC–MS/MS determination of apixaban (BMS-562247) and its major metabolite in human plasma: an application of polarity switching and monolithic HPLC column Pursley, Janice; Shen, Jim X.; Schuster, Alan Bioanalysis, Vol. 6, Issue 15 https://doi.org/10.4155/bio.14.66	journal	August 2014
Aging and the Anticoagulant Response to Warfarin Therapy Gurwitz, Jerry H. Annals of Internal Medicine, Vol. 116, Issue 11 https://doi.org/10.7326/0003-4819-116-11-901	journal	June 1992

Similar Records

Efficacy and safety of warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D

Journal Article · Thu Jan 27 23:00:00 EST 2022 · Clinical Kidney Journal · OSTI ID:1870521

Can Direct Oral Anticoagulants Be Used for Stroke Prevention Among Patients with Valvular Atrial Fibrillation?

Journal Article · Tue Oct 15 00:00:00 EDT 2019 · Current Cardiology Reports (Print) · OSTI ID:22929168

Influence of age on the relationship between apixaban concentration and anti-factor Xa activity in older patients with non-valvular atrial fibrillation

Citation Formats

References (24)

Similar Records

Related Subjects